Fitness tracker and smart watch maker Fitbit Inc (NYSE: FIT) reported a return to profit in its third-quarter print
Wednesday.
The Analysts
- Wedbush's Michael Pachter maintains an Outperform rating on Fitbit with
an unchanged $6.50 price target.
- William Blair's Jeffrey Garro maintains at Market Perform.
- Morgan Stanley's Yuuji Anderson maintains at Underweight with an unchanged $4 price target.
- Deutsche Bank's Jeffrey Rand maintains at Hold.
- Citi's Jim Suva maintains at Sell with an unchanged $5 price target.
Wedbush Sees M&A Possibilities
Fitbit's top-and-bottom-line in Q3 came in better than
expected and there's reason to believe the momentum can carry over through next year, Pachter said in a Thursday note.
The company maintained its full-year 2018 revenue guidance, which implies the potential for upside in the fourth quarter, as the
Charge 3 continues to be the top-selling Android-compatible wearable watch in the U.S., the analyst said.
Fitbit should start benefiting from medtech initiatives in 2019, Pachter said.
Fitbit's partnership with Google could be seen as a starting step toward Google acquiring Fitbit outright to compete
against Apple Inc. (NASDAQ: AAPL) in the
medtech space, he said, adding that "only a matter of time" before Fitbit's stock reflects the possibility of an acquisition.
William Blair: Meaningful Progress
Fitbit's Q3 could be viewed as "meaningful incremental progress" toward financial stability and a transition away from core
fitness trackers to devices that emphasize overall health, Garro said in a note.
Despite the seventh consecutive quarter of Fitbit reporting earnings ahead of its own guidance, the stock is trading at an
enterprise value of roughly 0.4 times 2019 sales, the analyst said. This multiple is balanced and factors in the company's
medtech opportunity, which could take time and be overshadowed by near-term demand trends with its existing products, he
said.
Related Link: Analyst
Upgrades Fitbit Ahead Of Push Into MedTech Space
Morgan Stanley: Some Confidence Returns
Fitbit's quarterly print should restore some confidence amid a competitive smart watch space and difficult activity tracker
market, Anderson said in a note. The company's revenue beat is likely due to the timing of new product launches, the analyst
said, adding that Fitbit's progress in releasing new features isn't compelling enough to stabilize declining demand.
Anderson cited three concerns to justify Morgan Stanley's bearish stance:
Non-device revenue fell 18 percent from a year ago and the contribution from Health Solutions is still small.
The gross margin of 40 percent was worse than expected.
Device sales fell in the quarter and will likely continue declining in the fourth quarter.
Deutsche Bank: Cautious Outlook
Fitbit's Q3 print shows unchanged smart watch momentum, and the company could see a "big holiday" season on the basis
of consumers looking for cheaper alternatives to the Apple Watch, Rand said in a note.
Investors should still hold a cautious stance on the stock given the uncertainty on whether the tracker business can grow
in the long run, the analyst said.
Citi: Not As Smart As Apple
Fitbit's earnings report is overshadowed by the reality that Fitbit's products "are not as smart" as the Apple Watch, Suva said
in a note. Nevertheless, the Q3 report is "good news" given the stock's 17-percent decline since the start of 2018 versus the
6-percent gain in the Nasdaq index, the analyst said.
Price Action
Fitbit shares were trading higher by more than 20 percent at the time of publication Thursday.
Related Link: Morgan
Stanley Stays Bearish On Fitbit After Apple Watch Unveil, Says Revenue Is The Real Concern
Photo courtesy of Fitbit.
Latest Ratings for FIT
Date |
Firm |
Action |
From |
To |
Oct 2018 |
Wedbush |
Upgrades |
Neutral |
Outperform |
Aug 2018 |
Bank of America |
Maintains |
Underperform |
Underperform |
Aug 2018 |
Wedbush |
Maintains |
Neutral |
Neutral |
View More Analyst Ratings for
FIT
View the Latest Analyst
Ratings
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.